Showing posts with label Covid-19. Show all posts
Showing posts with label Covid-19. Show all posts

Monday, September 20, 2021

Centre may give jabs to 12-17 years soon


12 crore children need to be vaccinated now

by Harish Gupta, National Editor, Lokmat Group

After achieving the target of giving 100 crore doses by month-end to adults, the Centre is set to announce its plans to vaccinate children in the age group of 12-17 years.

Of the 44 crore children population of all age groups below 18 years, the priority will be given to the 12-17 years category first.

When contacted, Prof N K Arora, Chairman of country’s top body, INSOCOG and Covid Task Force told Lokmat that the priority would be given to this age group as they could be carriers of Covid infections. Though the Sero-Surveys had established that the number of children infected with Covid is not higher than that of the adults. But they needed the vaccine now that most of the adult population had been covered with the first dose.

When asked when the decision would be taken in this regard, Prof Arora said, “It should come anytime now.”

In response to another question, he said, the vaccination of children in this category could start within the next couple of months. “In children as it is, severe disease and fatalities are uncommon. So, we have to ensure parents are safe first and children automatically become less vulnerable,” he added.

Arora added that children with comorbid conditions will be given priority in vaccination and even among them priority will be given to those who tend to have co-morbidities.

It is learnt that one percent children have co-morbidities out of the 12 crore children and the government had estimated that roughly 40 lakh such children will be given preference. The Jabs to them may start as early as October and may be free of cost. India’s drug regulator granted emergency use authorisation to Zydus Cadila’s vaccine, ZyCov-D, on August 20. This is India’s first vaccine for children aged above 12.

Saturday, April 3, 2021

Boris Johnson’s Pune, Mumbai trip in jeopardy

British PM is to visit two cities April end 

by Harish Gupta, National Editor, Lokmat 
New Delhi, April 2

Maharashtra's alarming Covid-19 situation and high positivist rate of more than 14% has put British Prime Minister Boris Johnson's visit to Pune & Mumbai in jeopardy.

Johnson is slated to visit New Delhi sometime on April 26-27 and as part of his itinerary was contemplating visiting Pune, Mumbai etc.

Johnson is eager to visit Pune which is the world's largest vaccine manufacture facility, Serum Institute of India (SII). SII has been producing Oxford Astrazeneca's vaccine Covishield, which has been exported to many countries from there. British officials are struggling to take a call on Pune visit and in touch with Indian counterparts.

This is the second time the British Prime Minister is contemplating visiting India. He was to be country's Chief Guest during the Republic Day celebrations on January 26. But Britain was hit hard by another Covid wave and lockdown was declared forcing cancellation of his trip.

The April trip was finalised when the situation started improving in the UK and it looked as if the second wave won't hit India. However, Maharashtra is among the worst hit among eight states. As if this was enough, Pune and Mumbai top the list of districts in highest reported cases. A night Curfew has been imposed in Pune from today and the situation continues to be alarming in Mumbai too.

The cases have risen at a rapid speed in Maharashtra from 15000 or so on March 15 and have trebled in less in 17 days. Though the state tops the country in terms of vaccination.

UK as the chair of the G7 grouping has invited India for the meeting of the grouping in June. Indian PM Modi will be traveling to the country for the summit, which could see its first in-person quad meeting as well. Both sides are also working on a trade deal.

Sunday, January 3, 2021

Covaxin Vaccine cleared for Emergency Use today

Govt. to buy Both --Covidshield or Covaxin 
Covidshield & Covaxin
Regulators to clear both vaccins soon

by Harish Gupta, National Editor, Lokmat Group

New Delhi, Jan 2
With the Emergency approval granted to Covaxin, jointly produced by Bharat Biotech-Indian Council of Medical Research late in the evening today, India has got another shot in its arm.

Covaxin is the country's 100% indigenous vaccine while Covidshield of Seerum Institute, Pune-Astrozeneca, UK was approved yesterday by the Subject Expert Committee (SEC) yesterday. The SEC cleared the Covaxin today. 

However, the formal approval of both the vaccines by the drug regulator Central Drug Standard Control Organisation (CDSCO) is yet to be granted.

While Seerum Institute has said that it already has stock-piled 40-50 million doses which it can supply to the Government of India by March this year itself, the authorities have not reacted to the proposal so far. In fact, the government has not signed any contract with the Seerum for the supply of Covidshield so far.

Neither Dr V K Paul who is head of the Prime Minister's Task Force on Vaccine management nor the Union Health Minister Dr Harsh Vardhan said anything so far as to which vaccine will be injected/inoculated to the 3 crore frontline health workers and other related categories. 

Whether the government will buy the Covidshield or Covaxin or a combination of both the vaccines for the Emergency usage, is still being worked out. 

For three crore frontline workers, India will need 60 million doses as every person has to be given two doses. As per the estimates, these three crore priority workers can be covered during the next four-five months. There is a strong possibility that the government may now involve the private sector in the entire vaccination drive. 

If the other population is also to be vaccinated at the earliest, the government will take a decision at the highest level. 

Secondly, the CDSCO and DCGI have yet to approve Covidshield and Covaxin. Once these medical bodies clear these vaccines for usage, various government institutions including the ministries of Health and others will take up follow-up action and allocate funds accordingly.

Sources say that the government will start the process around Makar Sankranti day on January 14 or so.

Monday, October 26, 2020

Covid Vaccine by March, Govt. hopeful

  • Availability & Distribution big problem 
Harish Gupta, National Editor, Lokmat Group
New Delhi, Oct 25

Even as a high-level National Expert Group on Vaccine Administration is working hard to prepare a blue-print as to who should be given the Vaccine first and how, encouraging reports are emerging about success of at least ten vaccines under trials globally.

The Prime Minister’s Task Force handling Vaccine program in tandem with countries and world agencies, is hopeful of availability of 3-4 vaccines early next year. Dr V K Paul headed Task Force reviewed Vaccine availability. Of them, at least three vaccines in India are at Phase-III of the trials of ten global vaccines undergoing phase-III trials. In addition to these 10, five Chinese vaccines are under trials in 20 countries and one is showing some success. A UAE minister was injected with the Chinese vaccine last week and is feeling fine.

The Bharat Biotech-ICMR joint venture drug Covaxin, ZydusCadila (phase-II) and Seerum-AstraZenca’s Covidshield is at Phase-III stage. In addition, Biological E, a Hyderabad based company is also testing a vaccine. This apart, Sputink V of Russia is also in phase II stage and crosses the hump for phase III trials.

Of the 154 vaccines in the preclinical phase, 44 in clinical trials, of which 10 are already in phase 3 trials, the first major success on this score may emerge by early next year. Florian Krammer, Professor of Vaccinology at the Icahn School of Medicine, Mount Sinai, U.S, Dr. Gagandeep Kang of Christian Medical College, Vellore and other experts said at a webinar said vaccines will be available early. Even if vaccines are eventually licensed and enter the market, there will be many hurdles to be crossed.

Dr Randeep Guleria, Director, AIIMS, said separately that it will take at least a year to immunize the whole country. He emphasized that India will have to keep evolving its vaccine distribution strategy, keeping in mind what is best for the country. Other experts felt that issues relating to large-scale production, distribution, success of the vaccine after it is inoculated, how long immunity will last etc. will need more careful handling.

Monday, October 5, 2020

Covid Vaccine may cost $5 per dose

India may have to spend Rs 50000 crores on Immunization

Harish Gupta, National Editor, Lokmat Group
New Delhi, Oct 5
India will need Rs 50,000 crores approximately to vaccinate 20-25 crores people during the next one year. This is based on the estimates that one dose of Covid vaccine will be available to India at a price of $4-5 per dose.

The Drug Controller General of India (DCGI) has signaled that Covid vaccine price will be under ₹1,000. Every person will require at least two doses for immunization.

India will require at least 40-50 crores doses. Though India has been assured vaccine supplies by the WHO and Global Vaccine Alliance (GAVI) promoted by the Gates Foundation and Indian vaccine manufacturers and pharma companies. 

This is far less than Rs 80,000 crores indicated by Adar Poonawalla of Seerum Institute of India a few days ago.

India may require at least 5 billion doses of vaccine if it is to immunize 25 crore population. The government is heavily dependent on AstraZeneca by University of Oxford being produced by the Seerum Institute and Bharat Biotech-ICMR joint project undergoing phase-II trials.

However, the Indian government has yet to make an upfront payment to pharma companies like the US, UK, European and other countries have made.

It is learnt that the Prime Minister’s Task Force headed by Dr V K Paul has been holding regular parleys with the global pharma chains researching and undertaking trials and also vaccine manufacturers who are producing vaccines on their behalf. India is a global vaccine hub and has a capacity of manufacturing two billion doses a year. These companies can ramp up production provided the government gives them facilities and funds.

The WHO has urged wealthier member states to join its Covid-19 vaccine, Covaxin, to ensure the equitable global distribution by end 2021. Gavi, the Global Alliance vaccine backed by the Gates Foundation, has raised $8.8 billion from world leaders and companies. The Bill & Melinda Gates Foundation pledged $1.6 billion.

Tuesday, September 15, 2020

Priyanka Gandhi Vadra quarantined, Cook Covid +ve

Harish Gupta, National Editor, Lokmat Group
Priyanka Gandhi


New Delhi, Sep 14

Priyanka Gandhi Vadra, AICC general secretary incharge of UP is understood to have been quarantined.

Highly placed sources in the Gandhi household say that since her cook has been found Covid positive, she has been advised home quarantined until September 21.

It was due to this sudden development that Priyanka Gandhi Vadra had to abandon her plans to accompany her mother Sonia Gandhi to the USA.

At the last minute, Rahul Gandhi had to chip in and go with the mother for her annual checkup. Rahul Gandhi had to skip the Parliament session though he was scheduled to take on the government on the very first day during the Zero Hour.

It is also emerging now that Priyanka Gandhi will shift from her Gurgaon residence and shift to Lutyen’s Delhi flat soon. Her new address will be a duplex apartment in Sujan Singh Park facing Ambassador Hotel near Khan Market.

The complex was built by author-editor Khushwant Singh’s father Sir Sobha Singh. Priyanka will be staying in the apartment as a tenant. It is learnt that Rahul Gandhi will come back early from the USA while Sonia Gandhi will stay back and later be joined by Priyanka Gandhi.

Friday, September 11, 2020

Asthana may be CBI Chief! Fly on the Wall

by Harish Gupta, National Editor, Lokmat Group

The three months long Rhea Chakraborty saga may finally come to an end after the Narcotics Control Bureau (NCB) doused the political fire in Bihar by arresting her. The graph of Rakesh Asthana, DG, NCB has jumped manifold in the eyes of political masters in Delhi. Asthana has succeeded where CBI Director R K Shukla and Enforcement Director Sanjay Kumar Mishra failed in the task even after 50 hours of grilling running for weeks together. A top ED officer who specially flew down from Delhi to Mumbai and part of the extensive grilling told his bosses: Sorry Sir! Not an iota of evidence.” Thus, the NCB stepped in. This column had said last week itself that NCB will arrest Rhea. Insiders tell us that Asthana’s prospects of becoming new CBI chief have brightened when Shukla retires early next year. Asthana had been extremely unhappy ever since he was shunted out from the CBI last year.


The 23 dissident Congress leaders are running for a cover after raising a banner of revolt against the Gandhis. Instead of buckling under the pressure, Congress’ interim president Sonia Gandhi has gone on the offensive. If she shocked dissidents by appointing Rahul loyalists in key parliamentary panels, she humiliated a few by dropping them from UP committees. As if this was not enough, Akhilesh Prasad Singh, Rajya Sabha MP and Bihar Campaign Committee chief was dropped from the powerful Bihar Election Committee. If sources are to be believed, the G-23 is a house divided with Mukul Wasnik, Manish Tewari and Shashi Tharoor singing different tunes. Tewari went public recently saying the letter’s drafting could have been better. Obviously, it’s a dig at Anand Sharma who drafted the letter. Tharoor is buying peace as BJP has no strong presence in Kerala while Mukul Wasnik has his own reasons for backtracking. Prithviraj Chavan who owed his rise to the post of Maharashtra Chief Minister to Sonia Gandhi, has gone into hiding after raising a banner of revolt.

Union Home Minister Amit Shah is back at his Krishna Menon Marg residence and recouping after suffering from Covid and fatigue. Being Prime Minister Modi’s Man Friday, Shah has been batting from the front foot. But for the past some time, he has been away from public glare.
The Fly learns that he is fully active and clearing files at a faster pace though avoiding attending office. The gossip mongers in Lutyen’s Delhi have all kinds of tails like Amit Shah being upset for not being invited to the Ram Janmabhoomi foundation stone laying ceremony, appointment of C R Patil as Gujrat BJP chief etc. etc. Insiders assert there is no truth as the equation between the PM-HM remains strong. The PM inquired about his health on a daily basis since August 2 when he was admitted to Medanta and visited him after he returned from AIIMS. These sources say, “Modi-Shah relationship is like that of Ram and Hanuman and no power on Earth can separate them.”

India’s flagship Air India is first on the block among the 26 PSUs to be sold before March 31 next year. While there are many takers for BPCL and others, selling Air India is turning out to be a Herculean task for the Civil Aviation Minister Hardeep Singh Puri. It transpires that the House of TATAs is somewhat disinclined. The TATAs already operate Air Asia & Vistara and CEO N Chandrasekaran is reluctant to put in this kind of money in the aviation business. However, two gulf nations have shown interest riding on the back of cordial relations with PM Modi. The government is keen to mop up at least two lakh crores from the PSU sale during 2020-21 to bridge 8% Budget deficit.

Monday, August 17, 2020

India conducts 3 crores Cvoid tests

  • Set to touch 10 lakh tests a day mark
  • Positivity rate coming down

by Harish Gupta, National Editor, Lokmat Group
New Delhi, Aug 16

India achieved a new milestone by conducting 3 crores coronavirus tests today. It touched 2.93 crores tests yesterday and with more than 7 lakh tests conducted till the time of going to the press, a new record has been set. India ramped up testing during the 15 days with a lightning speed that it could touch the three crore mark from two crores. Earlier, it took a month to touch the two crore mark. (see the table).

India is all set to make a record shortly when it will conduct 10 lakh coronavirus tests per day. It achieved a record 8.69 lakhs tests yesterday and if official sources are to be believed, the number will now touch 10 lakh tests a day mark anytime.

The Prime Minister had given the target to the ICMR to conduct 10 lakh tests per day on August 1. There was a time when India was testing less than 300 tests per day in March and touched the mind-boggling figure of 10 lakhs a day.

India conducts 3 crores Cvoid tests
The laboratories conducting Covid tests rose from 3 to 1500 in five months. Maharashtra alone has 144 labs including 67 in the private sector. 

The PM wanted states to undertake more tests so that the clear scenario could emerge and states ramped up testing on a large scale. The most heartening aspect is that the positivity rate of India has started coming down from 9.5% to 8.8% on August 15. Similarly, Maharashtra’s positivity rate came down from 20.2% on July 31 to 18.8% on August 15.

Official sources say that Covid cases are rising in the country rapidly. But this is largely due to very high testing and cases are coming down in percentage terms.

Thursday, August 13, 2020

India cautious in buying Russian Vaccine

PM Task Force on Covid Vaccine to meet again

Harish Gupta, National Editor, Lokmat Group
New Delhi, Aug 13

The Prime Minister’s high-powered Task Force on Vaccine headed by Dr V K Paul will be formulating its strategy to obtain the Russian vaccine to fight Covid pandemic.

The multi-member committee which met for several hours yesterday has not only to submit its report to the Prime Minister about the efficacy of the Russian Sputnik-V but also in how much quantity and what should be the funding mechanism.

The Task Force has to take a crucial decision about whether to procure several other Covid Vaccine candidates being manufactured in various parts of the world.

The Indian government has not assigned any fund for the research & development for Covid vaccines. Five vaccines are in the advanced stage of producing it including three Western and two Chinese. These all are in Phase 3 efficacy trials involving thousands of people.

Oxford University, working with the Swedish-British pharmaceutical group AstraZeneca, hopes to have results by September, while the US biotech company Moderna, partnering with the U.S. National Institutes of Health (NIH), is aiming for the end of the year, possibly November.

The Trump administration has spent nearly $ 10 billion to seven vaccine developers and signed manufacturing contracts with five of them to provide nearly one billion doses.

Japan is also negotiating with three suppliers and Britain is also signing deals with such manufacturers.

But India is banking on its own Convaxin being jointly produced by Bharat Biotech-ICMR and Zydus which are still in phase-I and Phase-II trials. The Task Force has to urgently take a view on Russian vaccine as it’s a friendly country. The presence of the secretary of the ministry of external affairs in the meeting indicates that India will try to obtain the Russian vaccine. The modalities are being worked out, these sources say.

Tuesday, August 11, 2020

PM Task Force Scouts for Covid Vaccine as Russia set to hit the market

Harish Gupta, National Editor, Lokmat Group
New Delhi, Aug 10
India is scouting on a war footing basis to obtain Covid vaccine as many leading global companies have gone into phase 3 trials. The Russian University has signaled to register its wonder drug early next week and go into mass production.

The Prime Minister’s Task Force on Vaccine procurement & management headed by Dr V K Paul is keeping a close watch on vaccines being tested by global players like Oxford, Cansino and Pfizer which have gone into phase-3 trials. With Indian vaccine trials still at an early stage, the PM’s Task Force is exploring alternative sources to procure vaccines from global sources.

According to WHO at least 165 vaccines for Coronavirus were being developed and 23 of them are in human trials including two drugs being tested in India. These drugs are still a far cry. 

Official sources, however, concede that India will have some difficulty as it has not made advance payments or invested in research & development of vaccines in any global company like many rich nations.

These sources insist “some grants have been made available from the department of biotechnology.” But these are meager amounts.

The Task Force is banking on the Bill Gates Milinda Foundation and also on Covax (Covid-19 Vaccine Global Access) in which some Indian companies and Bill and Melinda Gates Foundation have partnered. It is expected that this alliance (Gavi) will supply vaccines to low- and medium-income countries. The WHO’s Somumya Swaminathan has been on record that countries could go in for bilateral deals and it is for them to take the risk.

The Indian Council of Medical Research (ICMR) recently said in an official statement that the Covid vaccine be Made available to the health workers first. But a lot of efforts will be needed as demand for the covid vaccine will be huge as and when it hits the market.

At least one manufacturer of the vaccine in India told Lokmat on the condition of anonymity said that the government had not initiated any discussion with it on procurement of vaccines. India has the capability to produce two billion doses of vaccine.

Sunday, August 9, 2020

ICMR sets Aug 15 deadline for Covid Vaccine - AIIMS says Phase-I trials not over yet

“Covaxin initial results encouraging”, Dr Sanjay Rai AIIMS Principal Vaccine Investigator

Harish Gupta, National Editor, Lokmat Group

New Delhi, Aug. 9

PM Narendra Modi may have cut short bureaucratic delays to fast-track Coronavirus Vaccine trials in India. But the wonder drug will continue to elude as trials and may take longer than the August 15 deadline set by Indian Council of Medical Research.

It is authoritatively learnt that the Bharat Biotech’s Covaxin vaccine trials that began at the prestigious AIIMS and 11 other facilities across India last month, has not even completed Phase-I stage. The ICMR has partnered with the Hyderabad based Bharat Biotech to invent and manufacture vaccine.

Zydus Cadila’s ZyCov-D has was also been given permission for phase-I & II human clinical trials at its own facilities.

The ICMR raised the hopes when its director Dr Balram Bhargawa told reporters last week that phase-I and Phase-II trials for Covaxin drug would be completed before August 15.

But Dr Randeep Guleria, Director, AIIMS clarified, “We are rushing trials for the vaccine and clubbed phase-I & II trials. The human clinical trials will follow all safety norms.”

When contacted, Dr Sanjay Rai, Principal Investigator, AIIMS who is coordinating the Bharat Biotech’s Covaxin trials, told Lokmat this morning, “We have completed the Phase-I trials results which are very encouraging. There was no reaction to the drug. We gave single dose to Vaccine warriors and now double dose will be given to them to test its efficacy.”

In reply to a question, Dr Rai said phase-II trials will begin only after results of double dose are out in the next 10-15 days.

When asked why reports have been surfacing that the wonder drug will be out shortly, Dr Sanjay Rai said, “The government clubbed the phase-I & II clearances only. This was to cut delays and not aimed at compromising safety norms.”

Currently, trials of three vaccines including the one produced by the Oxford University & Seerum Institute, Pune are under way. Experts say that no Covid vaccine is likely to make it before the year-end.

Tuesday, August 4, 2020

India touches 2 crore Covid Test mark

  • Maharashtra doubles testing in July, UP Triples.
  • Delhi tops in per million population tests, Bihar refuses to test more

by Harish Gupta, National Editor, Lokmat Group
New Delhi, Aug. 1

India is set to touch two crores Covid testing mark ever since testing began in March this year. In a new record, more than one crores tests were conducted in the month of July itself according to data accessed from official sources. 

Of the two crores tests, five states alone- Maharashtra, Tamil Nadu, UP, Andhra Pradesh and Rajasthan – accounted for one crore tests. Maharashtra doubled its daily testing from 25182 tests on July 1 to 58192 tests on July 30. It also doubled its monthly testing from 9.95 lakh tests on July 1 to 20.21 lakhs on July 30. Similarly, India’s testing also doubled during July – from 2.18 lakh tests to 5.25 lakh tests yesterday. The Prime Minister has set a target of crossing 10 lakh tests per day on the back of ramping up testing capacity in the country.

However, it’s the national Capital of Delhi where the highest number of tests were conducted among per million people. It tested 50000 per million people while Maharashtra’s averaged 16,408 tests only. Maharashtra has one solace i.e. it is higher than the national average of 13181 tests per million. (see the table)

Till the end of June, testing was lacklustre across Maharashtra as different departments were involved in testing. But now all kinds of testing was brought under one department and it paid rich dividends, said a source in the state government. 

The data clearly showed that UP Chief Minister Yogi Adityanath set a record as the state is at number two in the country and its positivity rate is lowest with 3.6% only. Surprisingly, UP had conducted 7 lakh tests on July 1. But it tripled within one month to 21.20 lakh tests which is a record.

Compared with Bihar’s 'Sushashan Babu' as Nitish Kumar is known where 5 lakh tests have been conducted so far with a positivity rate of 9.1%. Its per million population test is the lowest in the country with 4160 tests. Sources in the Union Health Ministry say that low testing is despite repeated pleas by the PM and other agencies. 

Official sources say that with fatality rate down to 2.20% in the country and the virus is not deadly either, there is a hope that India will see Coronavirus peak sometime in September-October.

Wednesday, July 22, 2020

10,000 Vaccine Warriors needed, As trials for Corona drug begin

Harish Gupta, National Editor, Lokmat Group
New Delhi, July 22

After the Corona Warriors, India will need an army of “Vaccine Warriors” now. According to Drug Controller General of India (DGCI) and Union Health ministry estimates, the country will require at least 10000 “Vaccine Warriors”. The number may go up as more and more companies may start trials for the most-sought vaccine in the human history.

The response of people is tremendous in Delhi as AIIMS is flooded with requests for inclusion. More than 2000 applied while 375 needed

These warriors will undergo crucial trials being conducted by seven pharma companies during the next one year.

In Delhi’s AIIMS, the trial will begin tomorrow while in Goa the human trials began at the State’s Redkar Hospital today. In all, these trials are to be conducted at 12 locations across the country and 600 warriors will be administered first dose of Covaxin jointly produced by Bharat Biotech & ICMR. Then the same number will undergo for heavy doses and then the second phase will begin when 375 Vaccine Warriors will be needed.

These are called warriors as undergoing clinical trial is equally risky for the health and well being of the person.

The Prime Minister is personally monitoring the progress of these trials and talked to the Principal Scientific Adviser and co-chairman of the Task Force on Vaccine to get an update. The Task Force has Dr V K Paul, member NITI Aayog as its co-chair besides members of DRDO, Aayush, ICMR, DG Health Services.

The DCGI has permitted two vaccines -- one developed by the Bharat Biotech and another one by ZydusCadila Healthcare Ltd to conduct trials. At least five other companies including Panacea Biotec, Mynvax and Biological E are there. In addition, Serum Institute is on the verge of launching the Oxford vaccine as it is at phase III of the trials.

The Bharat Biotech’s vaccine trials over 1200 persons at 12 locations in India begins now. These sources say say one company would require around 1800-2000 such warriors during the next six months to one year.

Dr V G Somani, DCGI’s office declined to comment at this stage as to how many companies have been permitted for trials. Sources, however, said trials for the two more companies are set to begin soon.

Sunday, July 5, 2020

Fast-tracking Covid vaccine to cut red tape, safety norms in place: ICMR clarifies on Aug 15 deadline

Company hopeful; Vaccine may be launched after Phase-I, II trials

Harish Gupta ( National Editor, Lokmat Group)
New Delhi, July 4

The cat is out of the bag as to why the Indian Council of Medical Research (ICMR) set  August 15 date for developing and launch  a coronavirus vaccine.
It transpires that the developer of the most-sought vaccine in the world, Bharat Biotech company of Hyderabad, may be allowed to launch the vaccine immediately after the successful Phase-I and Phase-II trials without waiting for  four phases of trials which takes  minimum six months to one year. But in the instant case, the government and ICMR, may short-circuit the process.
A clue was given by none other but the Chairman and managing director of the Bharat Biotech company, Dr Krishna Ella himself.
When he was asked, “Is there anything that the government can do make sure that Covaxin can come into the market faster?” Dr Krishna Ella couldn’t resist his temptation.
Dr Krishna Ella told aa business daily on June 30, “ That is a decision for the government to take. If phase I & II data is good, it is up to the government and regulators. Our job is to execute the project and show the results.
It is clear that the vaccine can be launched after the phase-I and Phase-II trials if the regulators and government so permits.
Interestingly, the regulator (ICMR)  itself is a partner in the Covaxin with Bharat Biotech and Institute of Virology in Pune is also a partner which is owned by the government itself.
The ICMR which was playing coy since yesterday on the issue. Asserted today“the letter by DG-ICMR (Dr Balram Bhargava) to investigators of the clinical trial sites was meant to cut unnecessary red tape, without bypassing any necessary process, and speed up recruitment of participants."
“The process of Vaccine development “is exactly in accordance with the globally accepted norms to fast-track the vaccine development for diseases of pandemic potential wherein human and animal trials can continue in parallel."
Dr  Bhargava had sent out letters to 12 top clinical research agency  "envisaged" launching a novel coronavirus vaccine by Independence Day. The Union Health Ministry refused to comment and no government authority was willing to join the issue as it created a furore among experts and political class.

Thursday, July 2, 2020

Telangana tops in Covid +ve Cases rate Maharashtra slips to second slot

Corona Testing to touch One Crore Mark this week 
Harish Gupta (National Editor, Lokmat Group)
New Delhi, July 2
Telangana emerged on top of the Coronavirus cases in India in terms of percentage today. It pushed Maharashtra to the second slot and Delhi as cases are rising there very rapidly while these are on the decline in these hot spot states. This has caused a new worry to the Centre which had been nudging Telangana to conduct more tests.

The data accessed by Lokmat suggest from
official Health ministry sources revealed that positive cases touched a record high 18.7% pushing Maharashtra to 18.5% and Delhi 16.3%.

Though the number of Covid cases in Telanagana are 17357 only compared to Maharashtra’s 1.86 lakh and Delhi’s 89802 cases.  But these states (see the table) have undertaken record tests since February and due to sustained efforts, cases are on the decline.  Even these cases had not been possible had the Centre not pushed and the High Court not scolded the state for less tests. The daily testing in Telagana was just 1096 on June 17 which has now risen to 7691 until July 1 night.

If the positive cases were 269 cases on June 17, they rose to 17357 yesterday, a jump of more than 60 times in less than a fortnight.  The testing during the last fortnight rose seven times only – from 1096 tests to 7691 on July 1 night.

Surprisingly, neighbouring Andhra Pradesh


conducted 9.18 lakh tests and its positive cases rate is just 1.7% - lowest in the country.  But Maharashtra was on top in the country in conducting highest with 50825 tests. Interestingly, Tamil Nadu conducted 12.02 lakh cases and positive cases are 7.8%.

One Crore tests by this weekend
Interestingly, India will set a new record when it may cross one crore Covid test mark. It nearly touched  2.30 lakh tests per day record today.

India conducted 37.37 lakh tests on May 31 and positive cases were 4.9% which has now risen to 6.7%- a jump of nearly two percent. In terms of numbers, the cases rose from 1.82 lakhs to 6.04 lakhs..

Thursday, June 25, 2020

India Covid tests touch 75 lakh tests, Highest 2.15 lakh tests in a single day

* Number of positive cases rose to 6.2%
* Telangana jumps to 3rd slot after Maharashtra, Delhi
* 1000 laboratories testing in India
by Harish Gupta, National Editor, Lokmat Group
New Delhi, June 24
India achieved a new milestone in Covid-19 tests when it crossed two lakh tests a day. Until 9 this morning, more than 2.15 lakhs tests were conducted in a single day. The total number of tests in the country till date was 73.52 lakhs and set to cross 75 lakh tests mark by tonight. It is also heartening that the total number of laboratories in the country undertaking three type of tests rose to 1000 (730 government & 230 private) which is another record.

However, the data alarmingly revealed rising number of Covid-19 cases across India touching an all time high of 4.56 lakhs. The number of positive cases was 1.90 lakhs as on June 1 this year. But it more than doubled in merely 24 days. The percentage of cases (tests to positivity) also rose 4.96% to 6.2% during this period.

Data accessed by Lokmat from official sources revealed that positivity rate continues to soar by the day in Maharashtra  and Delhi with Telangana taking the third slot in the country.  (See the table)

Interestingly, Tamil Nadu is at the top in testing with 9.44 lakh tests and its positivity rate is less than Maharashtra (17.7%) and Delhi (16.6%).

On June 15, Maharashtra’s positivity rate was 15.9% and it conducted 6.59 lakh tests. Thus in less than 10 days it rose by 2% which is a sign of worry. Similarly, Delhi’s positivity rate was 14.2% on June 15. But it rose by 2.4% which is highest in term of percentage term.

The new state rapidly rising in positive cases is Telangana where positivity rate is 15.1%. It was no where on the scene on the map as it was not testing enough. However, within ten days of rapidly testing, it gained number 3 slot in the country.

Interestingly, UP and Maharashtra have highest number of laboratories with 110  and 105 respectively.

Saturday, April 11, 2020

Rising number of Hot Spots worries Centre, states

by Harish Gupta, National Editor, Lokmat Group


Rising number of Hot Spots worries Centre, states
1150 sealed off zones today

Harish Gupta

New Delhi, April 10


The Centre is extremely worried over the rising number of hot-spots or containment zones in states as total sealing and cordoning off large population is a new experience for state machinery. Even for the Centre it’s a new kind of challenge and strategy to deal with national-wide prolonged crisis is evolving by the day if not hour.

Sources in the Union Home Ministry say that there are as many as 1150 such hot-spots spread over 15 states and union territories. Earlier, the parameter for deciding the Hot-spots was 100 cases. But it has now been brought down to  ten considering the fact that enough testing could not be done. The best way was to seal off these areas first, confine the large population inside and undertake intensive testing. The antibody testing is now being done on a large scale.

Some of these cluster containment zones are as small as two lanes in a locality in Delhi and as large as Bhilwara in Rajasthan  where more than 20 lakh people were locked down from March 20 itself.
These sources say Maharashtra alone has more than 400 zones with Mumbai being the largest city in the country and Uttar Pradesh 105. Tamil Nadu is the second state where the number of containment zones is 222, 120 plus in Andhra Pradesh and 125 in Telangana.
It’s a matter of surprise that Covid-19 made serious inroads in Madhya Pradesh with 180 containment zones.
The Centre and state governments are working in complete tandem round the clock to monitor these hot-spots.   
The Centre is working on various modules to handle these clusters comprising more than 1150 hot-spots to contain spread of virus and give all facilities to the residents. The areas under drones and CCTV watch 24x7.
Special team of sanitary workers and health care and local officials going door-to-door. Mumbai has seen double digit growth has during the past two days taking the number to 380 hot-spots has sent shock waves. It is these rising number of hot-spots that has forced the hands of the Centre and states to extend the lock-down.
Ends 

Friday, April 10, 2020

Lockdown to continue But……..

by Harish Gupta, National Editor, Lokmat Group


Lockdown to continue But……..
Govt. Mulls opening some services  to  mitigate hardship
 Harish Gupta
 New Delhi, April 9

As the Covid19 cases are mounting by the day after more testing, the Centre is mulling whether to allow some more areas to open for activities in a staggered manner while continuing the lock-down.
Following areas are on the table of the government to open up after April 15 along with sealing of hot-spots and highly vulnerable areas and lock-down in other parts.
On the top of the agenda is to open up Food processing industry as new crop will arrive at the mandis with the harvesting season beginning from April 14. The vegetables and fruits markets alone cannot consume all products.
Whether to allow the e-commerce companies to open supply chain of essential goods and other goods worth Rs 40,000 crores locked down ready for delivery on roads in trucks and factory gates.
While truckers and service centers have  been opened up on the national highways, the roadside lakhs of eateries and related activities continue to remain shut.
Liquor shops, either owned by the state governments or in private sector is a major source of state revenue. Whether they should be opened for limited hours is also an issue on the table though not many are not in its favour.
How to allow the plumbers, electricians and other maintenance activity in a limited manner through permits be allowed.
Whether to allow the hailing taxi apps to operate service for  limited hours  is under consideration. This is coupled with allowing private vehicles with strict plying norms. There is a proposal that odd-even formula be introduced to curtail vehicular activity.
There is a complete No No for the opening of the Metro service and bus service. But three-wheeler with one passenger rule is under consideration.
Mobile shops and outlets of related activities companies be allowed for limited hours.
The agriculture labour and factory workers need to be moved out of their caves and how this should be done is a major issue.
Railway & Commerce Minister Piyush Goyal has also advocated opening up of certain essential industries be moved from their caves and need traveling facilities.
As of now, daily grocery and milk & milk products need, fruits & vegetables and agriculture activities have been opened up by the Centre. The medical supply chains also need work force to maintain supply line and e-commerce companies are virtually non-functional.
Reports of death of patients suffering from other ailments as most hospitals are now giving priority to Covid-19 patients
The 11 task forces set up by the Centre are considering various scenarios to be placed before the Group of Ministers headed by Rajnath Singh.

Thursday, April 9, 2020

Centre refutes Maharashtra charge

by Harish Gupta, National Editor, Lokmat Group


Centre refutes Maharashtra charge 
No Permission was needed to Hold Tablighi Markaz
Centre stepped in to diffuse crisis
Harish Gupta
New Delhi, April 8

The Centre today refused to be drawn into any controversy with the Tablighi Jamaat congregation at its Nizamuddin headquarters saying it was for the Delhi government to deal with it. 
The Delhi government, on its part, said since the conference was not to be held at a public place and inside its own six storeyed  building at Nizamuddin, no permission was needed. It was held inside their own building and for their own followers.
The Union Home Ministry deals only with the cases of those persons who come to India from abroad on various kinds of visas. The home ministry through the special branch of the police regularly keeps itself posted through a Foreigners register maintained by the holders of such conferences.  Since no permission was needed to hold a conference inside the Markaz from the special branch, no permission was given.
Without getting involved into the slinging match with the Maharashtra government, sources in the MHA  say that the Tablighi Jammat  was refused permission by the state as they wanted the conference to be held in an open area. But the case in Delhi was different as it was inside its own building.  There were no orders against holding any congregation before March 13 when it began.
The whole problem began when they refused to disperse after the conference on March 16.
Sources in the Home Ministry say that when the Delhi government headed by Chief Minister Arvind Kejriwal through the office of Lt. Governor Anil Baijal sought help in getting the followers of TJ dispersed and that too on March 22-23, the Delhi Police stepped in a formal manner.
The MHA sources refused to say anything with regard to the indulgence of National Security Adviser Ajit Doval to resolve the issue.
 However, sources in the PMO say that Doval has always been a backroom boy whenever it comes to handling tricky issues for the Prime Minister particularly relating to minorities. When the minorities were needed to be wooed in Jammu & Kashmir, Ajit Doval was deployed to undertake an extensive personal tour for three days and camped there.
Doval was the top official to visit the North East Delhi’s riot-stricken areas in February 27-28. Obviously, the PM deployed Doval as Amit Shah could not have done this for variety of reasons.
In the case of Tablighi Jamaat, the government tried hard to woo them through various sources including Prime Minister Narendra Modi’s close associate from Gujrat, Zafar Sareshwala who is a Tablighi himself. But the chief of the TJ, Moulana Saad refused to listen to him. Then Doval stepped in on March 28 to diffuse the situation.
Efforts to solicit response from Ajit Doval did not succeed and it remain a mystery as to why the Delhi Government, Delhi Police and  Union Home Ministry did not disperse the crowd immediately after the conference was over on March 15.

PM To hold meet with CMs on Lock down on April 11

by Harish Gupta, National Editor, Lokmat Group


PM To hold meet with CMs on Lock down on April 11

Harish Gupta
New Delhi, April 8
Prime Minister Narendra Modi will start the process of holding extensive consultations with Chief Ministers of states and union territories on April 11, Saturday.
Highly placed sources in the Prime Minister’s Office say this second interaction with the CMs will enable the government to take a final call on extending the country-wide lockdown or resort to easing of some of the restrictions.
The meeting with the Chief Ministers will be held through the video conference as was done earlier. The President and Vice President had also interacted with the Governors, Lieutenant Governors and administrators of Union Territories to directly assess the ground-level situation.
Since many states have advocated continuing the lock-down in the wake of mounting Covid-19 cases and results of large scale testing still in the pipeline, the most vulnerable states do not want to risk human lives. All agriculture related activities in states including of farm labour have already been permitted by the Central government. The Prime Minister is likely to obtain the views of the Chief Ministers about a way forward after April 14. In the last meeting the PM had sought the suggestions of the CMs on lifting the lockdown in a partial/staggered manner. Since many chief ministers have already expressed their views on the subject, the PM wants them to update the Centre their “final view” about the next course of action after April 14.
Sources say the government is exploring the reopening of certain sectors in a phased manner with huge restrictions. But it has not made up its mind  and wants to take a decision only after consulting the states. It is also pointed out that some of the state including Punjab had imposed lock-down even before the PM’s announcement of lockdown on March 24.  Capt. Amrinder Singh, Punjab Chief Minister, is on record to say that he will review the continuation of lock-down on April 10th evening. It is likely that all Chief Ministers will undertake a review in their own states and apprise the Centre on April 11.   
ends